Genetic variants that affect platelet function

Current Opinion in Hematology

Volumn 19, Issue 5, 2012, Pages 371-379

  Kunicki, Thomas J ^a   Williams, Shirley A ^a   Nugent, Diane J ^a  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

association study; gene; genome wide association studies; mean platelet volume; platelet count

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ALPHA2 INTEGRIN; BETA3 INTEGRIN; CELL SURFACE RECEPTOR; COLLAGEN; GLYCOPROTEIN IB ALPHA; PADGEM PROTEIN; THROMBOCYTE RECEPTOR;

AFRICAN AMERICAN; ETHNIC GROUP; FLOW CYTOMETRY; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOME; GENOTYPE; HEMATOPOIETIC STEM CELL; HUMAN; MEGAKARYOCYTE; META ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONTENT; QUANTITATIVE TRAIT LOCUS; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; THROMBOSIS; WISKOTT ALDRICH SYNDROME; X CHROMOSOME LINKED DISORDER;

BLOOD PLATELETS; GENETIC ASSOCIATION STUDIES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PLATELET COUNT; PLATELET FUNCTION TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CELL SURFACE; THROMBOSIS;

EID: 84865444625     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e3283567526     Document Type: Review

References (81)

1. Nurden A, Nurden P. Advances in our understanding of the molecular basis of disorders of platelet function. J Thromb Haemost 2011; 9 (Suppl 1):76-91.
2. Nurden AT, Fiore M, Nurden P, Pillois X. Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models. Blood 2011; 118:5996-6005.
3. von dem Borne AEGK. Nomenclature of platelet antigen systems. Br J Haematol 1990; 74:239-240.
4. Kunicki TJ, Nugent DJ. Platelet glycoprotein polymorphisms and relationship to function and immunogenicity. In: Coleman RW, Hirsch J, Marder VJ, Clowes AW, George JN, editors. Hemostasis and thrombosis, (6th ed). Philadelphia, PA: Lippincott Williams & Wilkins; 2012 (in press).
5. Huczek Z, Kochman J, Filipiak KJ, et al. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 2005; 46:284-290. (Pubitemid 40966857)
6. Kiliçli-Camur N, Demirtunç R, Konuralp C, et al. Could mean platelet volume be a predictive marker for acute myocardial infarction? Med Sci Monit 2005; 11:CR387-CR392. (Pubitemid 41224401)
7. Yilmaz MB, Cihan G, Guray Y, et al. Role of mean platelet volume in triagging acute coronary syndromes. J Thromb Thrombolysis 2008; 26:49-54.
8. Avci A, Boyaci A, Cagli K, et al. Influence of haematological parameters before coronary angioplasty on subsequent restenosis. Acta Cardiol 2004; 59:263-268. (Pubitemid 38787593)
9. Slavka G, Perkmann T, Haslacher H, et al.Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease. Arterioscler Thromb Vasc Biol 2011; 31:1215-1218.
10. Klovaite J, Benn M, Yazdanyar S, Nordestgaard BG. High platelet volume and increased risk of myocardial infarction: 39 531 participants from the general population. J Thromb Haemost 2011; 9:49-56.
11. Mayda-Domaç F, Misirli H, Yilmaz M. Prognostic role of mean platelet volume and platelet count in ischemic and hemorrhagic stroke. J Stroke Cerebrovasc Dis 2010; 19:66-72.
12. Butterworth RJ, Bath PM. The relationship between mean platelet volume, stroke subtype and clinical outcome. Platelets 1998; 9:359-364. (Pubitemid 28534785)
13. Greisenegger S, Endler G, Hsieh K, et al. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke 2004; 35:1688-1691. (Pubitemid 38823648)
14. Pikija S, Cvetko D, Hajduk M, Trkulja V. Higher mean platelet volume determined shortly after the symptom onset in acute ischemic stroke patients is associated with a larger infarct volume on CT brain scans and with worse clinical outcome. Clin Neurol Neurosurg 2009; 111:568-573.
15. Lowe GDO. Common risk factors for both arterial and venous thrombosis. Br J Haematol 2008; 140:488-495. (Pubitemid 351230085)
16. Braekken SK, Mathiesen EB, Njolstad I, et al. Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø study. J Thromb Haemost 2010; 8:157-162.
17. Kostrubiec M, Łabyk A, Pedowska-Włoszek J, et al. Mean platelet volume predicts early death in acute pulmonary embolism. Heart 2010; 96:460-465.
18. Biino G, Portas L, Murgia F, et al. A population-based study of an Italian genetic isolate reveals that mean platelet volume is not a risk factor for thrombosis. Thromb Res 2012; 129:e8-e13.
19. Boos CJ, Balakrishnan B, Lip GYH. The effects of coronary artery disease severity on time-dependent changes in platelet activation indices in stored whole blood. J Thromb Thrombolysis 2008; 25:135-140. (Pubitemid 351583661)
20. Latger-Cannard V, Hoarau M, Salignac S, et al. Mean platelet volume: comparison of three analysers towards standardization of platelet morphological phenotype. Int J Lab Hematol 2012; 34:300-310.
21. Thaulow E, Erikssen J, Sandvik L, et al. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991; 84:613-617.
22. Meade TW, Cooper JA, Miller GJ. Platelet counts and aggregation measures in the incidence of ischaemic heart disease (IHD). Thromb Haemost 1997; 78:926-929. (Pubitemid 27365594)
23. Folsom AR, Wu KK, Rosamond WD, et al. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997; 96:1102-1108. (Pubitemid 27344210)
24. Pizzi C, De Stavola BL, Meade TW. Long-term association of routine blood count (Coulter) variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I). Int J Epidemiol 2010; 39:256-265.
25. van der Bom JG, Heckbert SR, Lumley T, et al. Platelet count and the risk for thrombosis and death in the elderly. J Thromb Haemost 2009; 7:399-405.
26. Folsom AR, Rosamond WD, Shahar E, et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 1999; 100:736-742. (Pubitemid 29383644)
27. Kamath S, Blann AD, Lip GY. Platelet activation: assessment and quantification. Eur Heart J 2001; 22:1561-1571. (Pubitemid 32801301)
28. Chu SG, Becker RC, Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2010; 8:148-156.
29. Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996; 7:157-161. (Pubitemid 26167943)
30. Kunicki TJ, Williams SA, Nugent DJ, Yeager M. Mean platelet volume and integrin alleles correlate with levels of integrins aIIbb3 and a2b1 in acute coronary syndrome patients and normal subjects. Arterioscler Thromb Vasc Biol 2011; 32:147-152.
31. Yakushkin VV, Zyuryaev IT, Khaspekova SG, et al. Glycoprotein IIb-IIIa content and platelet aggregation in healthy volunteers and patients with acute coronary syndrome. Platelets 2011; 22:243-251.
32. Sirotkina OV, Khaspekova SG, Zabotina AM, et al. Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists. Platelets 2007; 18:506-514. (Pubitemid 350034854)
33. Fager AM, Wood JP, Bouchard BA, et al. Properties of procoagulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase. Arterioscler Thromb Vasc Biol 2010; 30:2400-2407.
34. George JN, Pickett EB, Saucerman S, et al. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 1986; 78:340-348. (Pubitemid 16074068)
35. Hardisty R, Pidard D, Cox A, et al. A defect of platelet aggregation associated with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet: the cause of a lifelong bleeding disorder. Blood 1992; 80:696-708.
36. Vetlesen A, Mirlashari MR, Ezligini F, Kjeldsen-Kragh J. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system. Transfusion 2007; 47:126-132. (Pubitemid 46006320)
37. Sabri S, Foudi A, Boukour S, et al. Deficiency in the Wiskott-Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartment. Blood 2006; 108:134-140. (Pubitemid 43990621)
38. Pallotta I, Lovett M, Rice W, et al. Bone marrow osteoblastic niche: a new model to study physiological regulation of megakaryopoiesis. PLoS One 2009; 4:e8359.
39. Noris P, Perrotta S, Seri M, et al. Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families. Blood 2011; 117:6673-6680.
40. Gieger C, Radhakrishnan A, Cvejic A, et al. New gene functions in megakaryopoiesis and platelet formation. Nature 2011; 480:201-208.
41. Lo KS, Wilson JG, Lange LA, et al. Genetic association analysis highlights new loci that modulate hematological trait variation in Caucasians and African Americans. Hum Genet 2011; 129:307-317.
42. Meisinger C, Prokisch H, Gieger C, et al. A genome-wide association study identifies three loci associated with mean platelet volume. Am J Hum Genet 2009; 84:66-71.
43. Soranzo N, Spector TD, Mangino M, et al. A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet 2009; 41:1182-1190.
44. Soranzo N, Rendon A, Gieger C, et al. A novel variant on chromosome 7q22.3 associated with mean platelet volume, counts, and function. Blood 2009; 113:3831-3837.
45. Kamatani Y, Matsuda K, Okada Y, et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat Genet 2010; 42:210-215.
46. Qayyum R, Snively BM, Ziv E, et al. A meta-analysis and genome-wide association study of platelet count and mean platelet volume in African Americans. PLoS Genet 2012; 8:e1002491.
47. Kuijpers RWAM, Ouwehand WH, Bleeker PMM, et al. Localization of the platelet-specific HPA-2 (Ko) alloantigens on the N-terminal globular fragment of platelet glycoprotein Ib-alpha. Blood 1992; 79:283-288.
48. Maguire JM, Thakkinstian A, Sturm J, et al. Polymorphisms in platelet glycoprotein 1balpha and factor VII and risk of ischemic stroke: a meta-analysis. Stroke 2008; 39:1710-1716.
49. Lasne D, Krenn M, Pingault V, et al. Interdonor variability of platelet response to thrombin receptor activation: influence of PIA2 polymorphism. Br J Haematol 1997; 99:801-807. (Pubitemid 28047142)
50. Goodall AH, Curzen N, Panesar M, et al. Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease. Eur Heart J 1999; 20:742-747. (Pubitemid 29209907)
51. Michelson AD, Furman MI, Goldschmidt-Clermont P, et al. Platelet GP IIIa PI(A) polymorphisms display different sensitivities to agonists. Circulation 2000; 101:1013-1018. (Pubitemid 30131704)
52. Theodoropoulos I, Christopoulos C, Metcalfe P, et al. The effect of human platelet alloantigen polymorphisms on the in vitro responsiveness to adrenaline and collagen. Br J Haematol 2001; 114:387-393. (Pubitemid 32762241)
53. Vijayan KV, Bray PF. Molecular mechanisms of prothrombotic risk due to genetic variations in platelet genes: Enhanced outside-in signaling through the Pro33 variant of integrin beta3. Exp Biol Med (Maywood) 2006; 231:505-513.
54. Kunicki TJ, Kritzik M, Annis DS, Nugent DJ. Hereditary variation in platelet integrin alpha2-beta1 copy number is associated with two silent polymorphisms in the alpha2 gene coding sequence. Blood 1997; 89:1939-1943.
55. Ajzenberg N, Berroeta C, Philip I, et al. Association of the-92C/G and 807C/T polymorphisms of the alpha2 subunit gene with human platelets alpha2beta1 receptor density. Arterioscler Thromb Vasc Biol 2005; 25:1756-1760. (Pubitemid 41098952)
56. Joutsi-Korhonen L, Smethurst PA, Rankin A, et al. The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression. Blood 2003; 101:4372-4379. (Pubitemid 36857801)
57. Trifiro E, Williams SA, Cheli Y, et al. The low-frequency isoform of platelet glycoprotein VIb attenuates ligand-mediated signal transduction but not receptor expression or ligand binding. Blood 2009; 114:1893-1899.
58. Lopez JA, Ludwig EH, McCarthy BJ. Polymorphism of human glycoprotein Ibalpha results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. J Biol Chem 1992; 267:10055-10061.
59. Ishida F, Furihata K, Ishida K, et al. The largest variant of platelet glycoprotein Ibz-has four tandem repeats of 13 amino acids in the macroglycopeptide region and a genetic linkage with Methionine 145. Blood 1995; 86:1356-1360.
60. Afshar-Kharghan V, Li CQ, Khoshnevis-Asl M, Lopez JA. Kozak sequence polymorphism of the glycoprotein (GP) Ibalpha gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex. Blood 1999; 94:186-191. (Pubitemid 29300148)
61. Kuijpers RWAM, Faber NM, Cuypers HTM, et al. NH2-Terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine 145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest 1992; 89:381-384.
62. Fontana P, Dupont A, Gandrille S, et al. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 2003; 108:989-995. (Pubitemid 37048230)
63. Dupont A, Fontana P, Bachelot-Loza C, et al. An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN. Blood 2003; 101:1833-1840. (Pubitemid 36237581)
64. Hetherington SL, Singh RK, Lodwick D, et al. Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP. Arterioscler Thromb Vasc Biol 2005; 25:252-257. (Pubitemid 40054285)
65. Fontana P, Gandrille S, Remones V, et al. Identification of functional polymorphisms of the thromboxane A2 receptor gene in healthy volunteers. Thromb Haemost 2006; 96:356-360. (Pubitemid 44377821)
66. Yabe M, Matsubara Y, Takahashi S, et al. Identification of ADRA2A polymorphisms related to shear-mediated platelet function. Biochem Biophys Res Commun 2006; 347:1001-1005. (Pubitemid 44118216)
67. Bennett JS, Catella-Lawson F, Rut AR, et al. Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets. Blood 2001; 97:3093-3099.
68. Payne KE, Bray PF, Grant PJ, Carter AM. Beta3 integrin haplotype influences gene regulation and plasma von Willebrand factor activity. Atherosclerosis 2008; 198:280-286. (Pubitemid 351707392)
69. Kunicki TJ. The influence of platelet collagen receptor polymorphisms in hemostasis and thrombotic disease. Arterioscler Thromb Vasc Biol 2002; 22:14-20. (Pubitemid 34076226)
70. Jones CI, Bray S, Garner SF, et al. A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways. Blood 2009; 114:1405-1416.
71. Johnson AD, Yanek LR, Chen M-H, et al. Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat Genet 2010; 42:608-613.
72. Watkins NA, O'Connor MN, Rankin A, et al. Definition of novel GP6 polymorphisms and major difference in haplotype frequencies between populations by a combination of in-depth exon resequencing and genotyping with tag single nucleotide polymorphisms. J Thromb Haemost 2006; 4:1197-1205.
73. Faraday N, Yanek LR, Yang XP, et al. Identification of a specific intronic PEAR1 gene variant associated with greater platelet aggregability and protein expression. Blood 2011; 118:3367-3375.
74. Schlossmann J, Ammendola A, Ashman K, et al. Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta. Nature 2000; 404:197-201. (Pubitemid 30154489)
75. Antl M, von Brü hl M-L, Eiglsperger C, et al. IRAG mediates NO/cGMPdependent inhibition of platelet aggregation and thrombus formation. Blood 2007; 109:552-559. (Pubitemid 46105953)
76. Martínez MC, Larbret F, Zobairi F, et al. Transfer of differentiation signal by membrane microvesicles harboring hedgehog morphogens. Blood 2006; 108:3012-3020.
77. Watkins NA, Gusnanto A, de Bono B, et al. A HaemAtlas: characterizing gene expression in differentiated human blood cells. Blood 2009; 113:e1-e9.
78. Freeman K, Farrow S, Schmaier A, et al. Genetic polymorphism of the alpha 2-adrenergic receptor is associated with increased platelet aggregation, baroreceptor sensitivity, and salt excretion in normotensive humans. Am J Hypertens 1995; 8:863-869.
79. Kambayashi J, Shinoki N, Nakamura T, et al. Prevalence of impaired responsiveness to epinephrine in platelets among Japanese. Thromb Res 1996; 81:85-90. (Pubitemid 26030949)
80. Croft SA, Samani NJ, Teare MD, et al. Novel platelet membrane glycoprotein VI dimorphism is a risk factor for myocardial infarction. Circulation 2001; 104:1459-1463. (Pubitemid 32917335)
81. Herrera-Galeano JE, Becker DM, Wilson AF, et al. A novel variant in the platelet endothelial aggregation receptor-1 gene is associated with increased platelet aggregability. Arterioscler Thromb Vasc Biol 2008; 28:1484-1490.